Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Globalisation



When national businesses become global operations… With the industry sourcing more raw materials and services from around the world and distributing its products in new markets, companies are adapting their business processes to suit a more complex global operating environment.

Megamerger Pfall-out? $160bn Pfizer-Allergan deal to hit CROs in short-term, analysts

24-Nov-2015 - The $160bn Pfizer-Allergan megamerger could lead to booking cancellations in the short-term say analysts, but CROs – especially Icon, Parexel and PPD - should ultimately benefit.

Recipharm reports 55% sales growth; North America next step in M&A strategy

05-Nov-2015 - Gaining a foothold in North America would complete Recipharm’s growth strategy in becoming a global CDMO leader, the firm says.

PRA assessing 'underperforming' JV in light of WuXi going private

04-Nov-2015 - Three year on, a joint venture with WuXi Pharmatech is underperforming according to PRA management and could be renegotiated when WuXi goes private.

CROs engaging in a ‘war on talent’, Quintiles CEO says

30-Oct-2015 - The fight between CROs for clinical research associates (CRAs) and people with certain other skillsets is hotting up, with both Icon and Quintiles identifying it as an issue faced by...

Russia's clinical trial approvals 'on the increase'

26-Oct-2015 - The number of clinical trials given the green light in Russia has increased 13% in the third quarter of the year, which could be thanks in part to a reduction...

Indian CMO latest acquisition in Recipharm's aggressive growth push

20-Oct-2015 - An agreement to buy Indian CMO Nitin boosts Recipharm’s presence in emerging markets and plays into its aggressive growth strategy, the firm says.

Dispatches from CPhI

EFCG: ‘API’ days for Europe as Big Pharma returns in search of quality

15-Oct-2015 - Big Pharma has returned to Europe for its API sourcing due to reasons of quality and reliability, according to the European Fine Chemicals Group (EFCG).

Can nuclear deal make Iran a contract manufacturing destination?

19-Aug-2015 - There’s little chance US companies will consider Iran as a venue for pharmaceutical contract manufacturing, even in the current era of limited détente between the two countries, experts say....

Biocon: IPO will evolve Syngene CRO into full manufacturing services firm

20-Jul-2015 - Indian CRO Syngene has received approval for its IPO prospectus paving the way to spin out from its parent company Biocon.

Marken ships trial supplies directly to patients in Korea as MERS tapers off

01-Jul-2015 - As the outbreak of Middle East Respiratory System (MERS) slows in South Korea, logistics supplier Marken has been granted government permission to deliver the first direct to patient (DTP) shipments...

Quintiles maintains 'outperform' rating following recent flurry of activity

25-May-2015 - A recent spate of activity - including the acquisition of a Japanese CRO and a secondary equity offering - has boosted Quintiles’ investment appeal, an analyst says.

Tigermed Envy? WuXi may be eyeing a launch on Shenzhen exchange

14-May-2015 - With WuXi pushing full steam ahead in its bid to go private, one expert says that the company may be envious of a competing CRO -- Hangzhou Tigermed, which is...

Chinese drugmaker looks West in market expansion deal with ELC Group

22-Apr-2015 - Understanding international regulatory demands, manufacturing standards and overcoming cultural barriers are key for Asian drugmakers looking to enter Western markets, says market access CRO ELC Group.

Quintiles pushes further into LatAm with Argentinian hospital alliance

17-Apr-2015 - Quintiles on Thursday announced the selection of Hospital Italiano of Buenos Aires, Argentina, as the company’s first “Prime Site” in Latin America, adding to the company’s network of investigative sites...

WuXi offers more details on the complexity of CRO, CMO competition

15-Apr-2015 - Competition in the notoriously tight-lipped CRO (contract research organization) and CMO (contract manufacturing organization) industries is getting fiercer as outsourcing picks up, though that hasn’t stopped one Chinese company from...

'Unjustified' ban of GVK-tested drugs has damaged India, says Pharmexcil

08-Apr-2015 - The reputation of Indian clinical trials has been damaged by the “unjustified” suspension of medicines tested by GVK Biosciences, Pharmexcil says as it attacks the evidence submitted by French regulators.

AMRI sets sights on acquiring Indian API manufacturer, CEO says

11-Mar-2015 - Following its three acquisitions over the last year, AMRI is now looking to extend its footprint into India further with the acquisition of a FDA-approved API site, William Marth, president...

Exclusive interview

Preclinical prices improving says Huntingdon CEO; firm is mulling US capacity expansion

05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told the preclinical CRO may add scale to US...

Patheon: Irix deal about US and Canadian customer demand for local APIs; all staff to be retained

05-Mar-2015 - Irix Pharmaceuticals will cater for North American customers’ desire for local supply according to Patheon, which says it plans to retain the API firm’s 180 staff.

Waters 2014: Global growth led by generic drugmakers in India

27-Jan-2015 - Sales of consumables and analytical tools grew 20% in India in 2014 due to demand from generic drugmakers, says Waters Corporation.

PPD adds cell-based assay services in Ireland to service EU demand

22-Jan-2015 - PPD is expanding its GMP services in Ireland to support regulatory requirements for the growing number of biopharmaceutical drugs in development.

Ocean rises for drug transportation due to cost and cold chain concerns

15-Jan-2015 - AstraZeneca and Baxter are opting to transport pharmaceuticals by ocean and land routes as costs and cold chain security drive a drop in air freight.

Shareholder nod for Medtronic and Covidien's $43bn 'strategic' merger

07-Jan-2015 - The $43bn (€36bn) megamerger between Medtronic and Covidien is one step closer after shareholders voted to approval the deal yesterday.

Cromos offers free clinical trials to cash-strapped small and mid-sized pharmas

18-Dec-2014 - Cromos Pharma has launched a free or reduced cost trial model to help small and mid-sized drugmakers overcome the funding Catch-22 that can derail development efforts.

News in brief

WuXi to bolster US presence with Boston and San Francisco offices

15-Dec-2014 - WuXi PharmaTech is increasing its presence in the US announcing the opening of offices on the East and West coast.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...